Jazz Pharmaceuticals plc buy Wells Fargo & Company
Start price
06.05.26
/
50%
€192.05
Target price
06.05.27
€226.10
Performance (%)
10.96%
Price
13.08.26
€213.10
Summary
This prediction is currently active. The prediction currently has a performance of 10.96%. This prediction currently runs until 06.05.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -4.592% | -4.592% |
| iShares Core DAX® | 0.625% | 4.952% |
| iShares Nasdaq 100 | 1.160% | -1.160% |
| iShares Nikkei 225® | 2.356% | -1.354% |
| iShares S&P 500 | 0.631% | 1.380% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $250.00 to $265.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€219.00
04.08.26
04.08.26
-
04.08.27
04.08.27
-2.69%
13.08.26
13.08.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€207.50
14.07.26
14.07.26
€250.17
14.07.27
14.07.27
2.99%
13.08.26
13.08.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€162.75
25.02.26
25.02.26
€212.10
25.02.27
25.02.27
30.94%
13.08.26
13.08.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€155.95
18.11.25
18.11.25
€202.73
18.11.26
18.11.26
36.65%
13.08.26
13.08.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.00
13.02.25
13.02.25
€163.54
13.02.26
13.02.26
6.50%
14.02.26
14.02.26